RhumbLine Advisers’s Tivity Health, Inc. Common Stock TVTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-120,612
| Closed | -$3.88M | – | 3333 |
|
|
2022
Q1 | $3.88M | Buy |
120,612
+1,775
| +1% | +$48K | 0.01% | 1468 |
|
|
2021
Q4 | $3.14M | Buy |
118,837
+1,714
| +1% | +$43.6K | ﹤0.01% | 1628 |
|
|
2021
Q3 | $2.7M | Sell |
117,123
-5,808
| -5% | -$138K | ﹤0.01% | 1721 |
|
|
2021
Q2 | $3.23M | Sell |
122,931
-7,815
| -6% | -$196K | ﹤0.01% | 1679 |
|
|
2021
Q1 | $2.92M | Buy |
130,746
+928
| +0.7% | +$21.3K | ﹤0.01% | 1727 |
|
|
2020
Q4 | $2.54M | Buy |
129,818
+8,706
| +7% | +$145K | ﹤0.01% | 1731 |
|
|
2020
Q3 | $1.7M | Sell |
121,112
-17,516
| -13% | -$253K | ﹤0.01% | 1767 |
|
|
2020
Q2 | $1.57M | Sell |
138,628
-26,595
| -16% | -$243K | ﹤0.01% | 1861 |
|
|
2020
Q1 | $1.04M | Buy |
165,223
+10,172
| +7% | +$164K | ﹤0.01% | 1867 |
|
|
2019
Q4 | $3.15M | Buy |
155,051
+7,410
| +5% | +$139K | 0.01% | 1530 |
|
|
2019
Q3 | $2.46M | Buy |
147,641
+1,454
| +1% | +$25.1K | ﹤0.01% | 1619 |
|
|
2019
Q2 | $2.4M | Buy |
146,187
+13,535
| +10% | +$261K | ﹤0.01% | 1621 |
|
|
2019
Q1 | $2.33M | Buy |
132,652
+18,478
| +16% | +$393K | ﹤0.01% | 1625 |
|
|
2018
Q4 | $2.83M | Buy |
114,174
+21,834
| +24% | +$726K | 0.01% | 1447 |
|
|
2018
Q3 | $2.97M | Buy |
92,340
+4,714
| +5% | +$161K | 0.01% | 1433 |
|
|
2018
Q2 | $3.08M | Buy |
87,626
+4,151
| +5% | +$153K | 0.01% | 1429 |
|
|
2018
Q1 | $3.31M | Buy |
83,475
+1,650
| +2% | +$64.1K | 0.01% | 1301 |
|
|
2017
Q4 | $2.99M | Buy |
81,825
+10,700
| +15% | +$406K | 0.01% | 1385 |
|
|
2017
Q3 | $2.9M | Buy |
71,125
+1,445
| +2% | +$56K | 0.01% | 1365 |
|
|
2017
Q2 | $2.78M | Buy |
69,680
+2,912
| +4% | +$97.4K | 0.01% | 1366 |
|
|
2017
Q1 | $1.94M | Buy |
66,768
+18,426
| +38% | +$486K | ﹤0.01% | 1570 |
|
|
2016
Q4 | $1.1M | Sell |
48,342
-883
| -2% | -$20.8K | ﹤0.01% | 1803 |
|
|
2016
Q3 | $1.3M | Buy |
49,225
+2,265
| +5% | +$45.7K | ﹤0.01% | 1676 |
|
|
2016
Q2 | $542K | Sell |
46,960
-8,125
| -15% | -$95.1K | ﹤0.01% | 2144 |
|
|
2016
Q1 | $556K | Buy |
55,085
+4,595
| +9% | +$51.6K | ﹤0.01% | 2151 |
|
|
2015
Q4 | $650K | Buy |
50,490
+1,825
| +4% | +$22.2K | ﹤0.01% | 2080 |
|
|
2015
Q3 | $541K | Buy |
48,665
+854
| +2% | +$10.4K | ﹤0.01% | 2174 |
|
|
2015
Q2 | $573K | Buy |
47,811
+2,825
| +6% | +$46.9K | ﹤0.01% | 2236 |
|
|
2015
Q1 | $886K | Buy |
44,986
+2,660
| +6% | +$55.6K | ﹤0.01% | 1934 |
|
|
2014
Q4 | $841K | Sell |
42,326
-1,100
| -3% | -$18K | ﹤0.01% | 1931 |
|
|
2014
Q3 | $696K | Buy |
43,426
+250
| +0.6% | +$4.24K | ﹤0.01% | 2006 |
|
|
2014
Q2 | $757K | Sell |
43,176
-2,032
| -4% | -$34.9K | ﹤0.01% | 2008 |
|
|
2014
Q1 | $775K | Sell |
45,208
-1,820
| -4% | -$28K | ﹤0.01% | 1964 |
|
|
2013
Q4 | $722K | Sell |
47,028
-2,390
| -5% | -$33.9K | ﹤0.01% | 2026 |
|
|
2013
Q3 | $915K | Buy |
49,418
+524
| +1% | +$9.47K | ﹤0.01% | 1838 |
|
|
2013
Q2 | $850K | Buy |
+48,894
| New | +$674K | ﹤0.01% | 1879 |
|
Other funds holding TVTY
BCMLT
PP
RhumbLine Advisers's TVTY Position: Q2 2022 in Review
RhumbLine Advisers sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 120,612 shares — an estimated $3.88M sold.
RhumbLine Advisers first reported a position in TVTY in Q2 2013 and held it in 36 quarters. The position peaked at $3.88M in Q1 2022. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.
- RhumbLine Advisers reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- RhumbLine Advisers sold 120,612 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $3.88M.
- RhumbLine Advisers first reported a position in Tivity Health, Inc. Common Stock in Q2 2013 and held it in 36 quarters.
- RhumbLine Advisers's Tivity Health, Inc. Common Stock position peaked at $3.88M in Q1 2022.
- 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.
Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.